Drug Profile
Clopidogrel/aspirin - Hanmi Pharmaceutical
Alternative Names: aspirin/clopidogrel - Hanmi PharmaceuticalLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Hanmi Pharmaceutical
- Class 2 ring heterocyclic compounds; Antiplatelets; Antipyretics; Chlorobenzenes; Esters; Pyridines; Salicylic acids; Small molecules; Thienopyridines
- Mechanism of Action Cyclooxygenase inhibitors; Platelet aggregation inhibitors; Purinergic P2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Acute coronary syndromes
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Acute coronary syndromes(In volunteers) in South Korea (PO)